Go Pro
→ ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (From Brownstone Research) (Ad)tc pixel Free CRDL Stock Alerts

Cardiol Therapeutics (CRDL) Short Interest Ratio & Short Volume

Cardiol Therapeutics logo
$1.18 -0.05 (-4.07%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$1.18 0.00 (-0.42%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Cardiol Therapeutics Short Interest Overview

As of July 15, 2026, Cardiol Therapeutics (CRDL) had a short interest of 2.21 million shares sold short, representing 2.02% of the public float. This marks a -0.31% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.7, meaning it would take 2.7 days of the average trading volume of 798,015 shares to cover all short positions.

Current Short Interest
2,210,924 shares
Previous Short Interest
2,217,703 shares
Change Vs. Previous Month
-0.31%
Dollar Volume Sold Short
$2.45 million
Short Interest Ratio
2.7 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
115,250,000 shares
Short Percent of Float
2.02%
Today's Trading Volume
679,843 shares
Average Trading Volume
798,015 shares
Today's Volume Vs. Average
85%
Short Selling Cardiol Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Cardiol Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRDL Short Interest Over Time

CRDL Days to Cover Over Time

CRDL Percentage of Float Shorted Over Time

Cardiol Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20262,210,924 shares $2.45 million -0.3%2.0%2.71 $1.11
6/30/20262,217,703 shares $2.35 million +6.4%2.0%6.52 $1.06
6/15/20262,084,149 shares $2.19 million +8.7%1.9%5.24 $1.05
5/29/20261,918,255 shares $2.34 million -2.1%1.8%6.44 $1.22
5/15/20261,958,996 shares $2.59 million -0.3%1.8%4.46 $1.32
4/30/20261,965,344 shares $2.71 million -0.9%1.9%2.31 $1.38
4/15/20261,982,828 shares $2.84 million +0.1%1.8%3.04 $1.43
3/31/20261,981,485 shares $2.68 million -5.6%1.8%1.55 $1.35
2/27/20262,245,658 shares $2.29 million +7.8%2.1%7.35 $1.02
2/13/20262,084,133 shares $2.17 million +2.5%1.9%5.41 $1.04
11/14/20251,891,917 shares $1.93 million +1.5%2.0%5.37 $1.02
10/31/20251,863,417 shares $2.11 million -8.5%2.0%2.1 $1.13
10/15/20252,040,000 shares $2.20 million -7.3%2.6%2.1 $1.08
9/30/20252,200,000 shares $2.35 million +0.5%2.8%2.5 $1.07
9/15/20252,190,000 shares $2.37 million -8.8%2.8%2.8 $1.08
8/31/20252,400,000 shares $2.59 million +28.3%3.0%3.4 $1.08
8/15/20251,870,000 shares $2.45 million +6.3%2.4%3 $1.31
7/31/20251,760,000 shares $2.62 million +2.3%2.2%4.3 $1.49
7/15/20251,720,000 shares $2.22 million -7.5%2.2%7.8 $1.29
6/30/20251,860,000 shares $2.53 million -2.6%2.4%9.5 $1.36
6/15/20251,910,000 shares $2.79 million -4.0%2.4%9.4 $1.46
5/31/20251,990,000 shares $2.48 million +8.2%2.5%9.7 $1.25
5/15/20251,840,000 shares $2.10 million -8.9%2.3%9.4 $1.14
4/30/20252,020,000 shares $2.22 million -1.0%2.6%9.1 $1.10
4/15/20252,040,000 shares $2.16 million +10.3%2.6%8.7 $1.06
3/31/20251,850,000 shares $1.79 million +5.1%2.4%7.3 $0.97
3/15/20251,760,000 shares $1.99 million -5.9%2.3%6.5 $1.13
2/28/20251,870,000 shares $2.15 million +26.4%2.4%6.2 $1.15
2/15/20251,480,000 shares $1.81 million +3.5%1.9%4.5 $1.22
1/31/20251,430,000 shares $2.02 million -8.3%1.8%4 $1.41
1/15/20251,560,000 shares $1.92 million +18.2%2.0%4.3 $1.23
12/31/20241,320,000 shares $1.69 million +3.9%1.7%2.7 $1.28
12/15/20241,270,000 shares $1.69 million +12.4%1.6%2.6 $1.33
11/30/20241,130,000 shares $1.83 million +26.5%1.5%2.3 $1.62
11/15/2024893,300 shares $1.63 million +9.6%1.2%1.9 $1.82
10/31/2024814,800 shares $1.47 million -17.8%1.2%1.9 $1.80
10/15/2024991,600 shares $1.89 million +39.6%1.5%2.4 $1.91
9/30/2024710,500 shares $1.41 million -1.1%1.1%1.8 $1.98
9/15/2024718,400 shares $1.78 million -0.9%1.1%2.3 $2.48
8/31/2024724,600 shares $1.41 million -3.7%1.1%1.7 $1.94
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (Ad)

Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel

See Jeff Brown and Marc Chaikin's full analysis and next steps here
8/15/2024752,500 shares $1.54 million -4.3%1.1%1.6 $2.04
7/31/2024786,600 shares $1.70 million +2.5%1.2%1.6 $2.16
7/15/2024767,700 shares $1.64 million -13.6%1.2%1.5 $2.13
6/30/2024888,500 shares $1.79 million +14.5%1.4%1.8 $2.02
6/15/2024776,300 shares $1.87 million +107.6%1.2%1.5 $2.41
5/31/2024374,000 shares $979.88 thousand +40.3%0.6%1 $2.62
5/15/2024266,500 shares $618.28 thousand -18.8%0.4%0.8 $2.32
4/30/2024328,100 shares $659.48 thousand +19.2%0.5%0.8 $2.01
4/15/2024275,200 shares $492.61 thousand -15.7%0.4%0.7 $1.79
3/31/2024326,600 shares $591.15 thousand +19.6%0.5%0.8 $1.81
3/15/2024273,000 shares $414.96 thousand -24.4%0.4%0.8 $1.52
2/29/2024361,100 shares $743.87 thousand +108.1%0.6%1.1 $2.06
2/15/2024173,500 shares $256.78 thousand +16.6%0.3%0.6 $1.48
1/31/2024148,800 shares $181.54 thousand +24.4%0.2%0.9 $1.22
1/15/2024119,600 shares $124.38 thousand -9.1%0.2%0.8 $1.04
12/31/2023131,500 shares $110.88 thousand -31.4%0.2%0.7 $0.84
12/15/2023191,800 shares $165.93 thousand -14.7%0.3%0.9 $0.87
11/30/2023224,800 shares $206.03 thousand -11.9%0.4%1 $0.92
11/15/2023255,200 shares $214.37 thousand -17.5%0.4%1.2 $0.84
10/31/2023309,500 shares $256.89 thousand -4.8%0.5%1.4 $0.83
10/15/2023325,100 shares $266.58 thousand +32.1%0.5%1.2 $0.82
9/30/2023246,100 shares $220.26 thousand +132.0%0.4%1.2 $0.90
9/15/2023106,100 shares $103.45 thousand +46.6%0.2%0.6 $0.98
8/31/202372,400 shares $79.64 thousand -49.2%0.1%0.4 $1.10
8/15/2023142,400 shares $134.48 thousand +8.5%0.2%0.8 $0.94
7/31/2023131,200 shares $141.70 thousand +49.3%0.2%0.7 $1.08
7/15/202387,900 shares $71.54 thousand +3.8%0.1%0.7 $0.81
6/30/202384,700 shares $75.38 thousand -26.7%0.1%0.6 $0.89
6/15/2023115,500 shares $91.53 thousand -23.8%0.2%0.8 $0.79
5/31/2023151,500 shares $102.13 thousand +1.3%0.3%1.3 $0.67
5/15/2023149,600 shares $82.28 thousand +18.8%0.2%1.5 $0.55
4/30/2023125,900 shares $78.01 thousand -21.1%0.2%1.1 $0.62
4/15/2023159,500 shares $82.54 thousand -12.9%0.3%1.5 $0.52
3/31/2023183,100 shares $89.22 thousand +8.9%0.3%1.8 $0.49
3/15/2023168,100 shares $82.37 thousand +8.3%0.3%1.7 $0.49
2/28/2023155,200 shares $82.32 thousand -41.3%0.3%1.3 $0.53
2/15/2023264,500 shares $150.77 thousand -10.0%0.5%2.2 $0.57
1/31/2023293,800 shares $206.92 thousand +8.9%0.5%2.3 $0.70
1/15/2023269,800 shares $217.35 thousand +6.7%0.5%1.9 $0.81
12/30/2022252,900 shares $128.98 thousand +11.0%0.4%1.5 $0.51
12/15/2022227,800 shares $152.63 thousand -3.1%0.4%1.1 $0.67
11/30/2022235,100 shares $121.15 thousand +10.3%0.4%1 $0.52
11/15/2022213,100 shares $135.17 thousand -10.8%0.4%0.8 $0.63
10/31/2022239,000 shares $143.11 thousand -33.0%0.4%0.9 $0.60
10/15/2022356,900 shares $232.70 thousand -29.6%0.6%1.4 $0.65
9/30/2022506,600 shares $521.80 thousand +2.2%0.9%2.2 $1.03
9/15/2022495,800 shares $609.83 thousand +3.1%0.9%2.6 $1.23
8/31/2022481,100 shares $538.83 thousand +22.4%0.8%3.1 $1.12
8/15/2022393,200 shares $499.36 thousand +9.2%0.7%2.8 $1.27
7/31/2022360,200 shares $475.46 thousand -9.4%0.6%2.5 $1.32
I’ll Keep This Short… (Huge AI Opportunity) (Ad)

Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - it's a small, under-the-radar stock trading for just a few dollars. This company holds 98 registered patents in voice and sound recognition technology and has secured partnerships with Honda, Netflix, Pandora, and Mercedes-Benz.tc pixel

Get the full details on this under-the-radar AI stock now
7/15/2022397,700 shares $505.08 thousand -17.5%0.7%2.2 $1.27
6/30/2022482,300 shares $636.64 thousand -13.1%0.8%1.8 $1.32
6/15/2022554,700 shares $787.67 thousand +44.8%1.0%1.9 $1.42
5/31/2022383,100 shares $513.35 thousand -13.4%0.7%1.3 $1.34
5/15/2022442,400 shares $522.03 thousand -14.1%0.8%1.5 $1.18
4/30/2022514,700 shares $705.14 thousand -2.8%0.9%1.7 $1.37
4/15/2022529,600 shares $1.09 million +65.7%0.9%1.7 $2.05
3/31/2022319,600 shares $488.99 thousand -20.5%0.6%1 $1.53
3/15/2022401,900 shares $566.68 thousand +4.6%0.7%1.2 $1.41
2/28/2022384,100 shares $645.29 thousand -11.0%0.7%1 $1.68
2/15/2022431,500 shares $781.02 thousand +13.3%0.8%1.1 $1.81
1/31/2022381,000 shares $704.85 thousand +119.3%0.7%0.7 $1.85
1/15/2022173,700 shares $347.40 thousand -27.2%0.7%0.2 $2.00
12/31/2021238,600 shares $441.41 thousand No Change1.0%0.3 $1.85

CRDL Short Interest - Frequently Asked Questions

Short interest is the volume of Cardiol Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 2,210,924 shares of CRDL short. 2.02% of Cardiol Therapeutics' shares are currently sold short. Learn More on Cardiol Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDL shares currently have a short interest ratio of 2.7. Learn More on Cardiol Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.02% of Cardiol Therapeutics' floating shares are currently sold short.

Cardiol Therapeutics saw a drop in short interest in July. As of July 15th, there was short interest totaling 2,210,924 shares, a drop of 0.3% from the previous total of 2,217,703 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.02% of Cardiol Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cardiol Therapeutics: Immix Biopharma, Inc. (22.42%), Relmada Therapeutics, Inc. (14.49%), Contineum Therapeutics, Inc. (7.10%), Eikon Therapeutics, Inc. (8.55%), Zura Bio Limited (12.33%), Aquestive Therapeutics, Inc. (14.26%), Arvinas, Inc. (6.65%), Ginkgo Bioworks Holdings, Inc. (9.13%), REGENXBIO Inc. (19.45%), Nuvectis Pharma, Inc. (7.98%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling CRDL is an investing strategy that aims to generate trading profit from Cardiol Therapeutics as its price is falling. CRDL shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cardiol Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDL, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRDL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CRDL) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
BlackRock's $2.8B Clue (most investors missed)
BlackRock's new fund on the emerging financial grid hit 2.8 billion in assets in just three months, according ...
Awesomely | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
August 6 could be a BIG day for one AI company
One AI company's revenue has surged 757 percent in the past year, earning it an A rating from Louis Navellier'...
InvestorPlace | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel